Reimbursement for use of the artificial intelligence (AI)-powered EchoGo Heart Failure platform in hospital outpatient settings for Medicare and Medicaid patients is expected to increase from $99.81 to $284.88 in 2024.
Use of an FDA-cleared artificial intelligence (AI)-enabled system, which reportedly facilitates earlier detection of heart failure with preserved ejection fraction (HFpEF), will generate higher outpatient reimbursement in 2024, according to newly issued coding updates from the Centers for Medicare and Medicaid Services (CMS).
In an update to the ambulatory payment classification (APC) for the Healthcare Common Procedure Coding System (HCPCS) code C9786, the CMS has increased reimbursement from $99.81 to $284.88 for use of the EchoGo Heart Failure system, according to Ultromics, the manufacturer of the platform. The increased reimbursement for the device will go into effect on January 1, 2024.
The EchoGo Heart Failure platform, which received FDA 510(k) clearance in December 2022, reportedly diagnoses HFpEF through analysis of a single echocardiogram view. An August 2023 study noted a 95 percent area under the receiver operating characteristic curve (AUC) in validation testing for HFpEF detection.
“Approximately 50 percent of non-invasive cardiac imaging tests are performed in office-based settings so there is exciting potential for this reimbursement decision to unlock new opportunity to further broaden adoption of our technology,” added Ross Upton, the CEO and founder of Ultromics.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.